I do worry about their disregard for IP though. What is stopping some entity in China from selling their own Vascepa? They don't care and will even use the same logo. Seen this for years in Asia. It's strange.
So you have China with possibly the reduce it label, Europe, 90% of US market and trials for colon cancer, Alzheimer’s etc etc etc and ultimate payout for some of you that you would be happy with is $15???